Quebec To Be Well Represented At Philadelphia's World-Class Biotechnology Convention
MONTREAL, June 17 /PRNewswire/ - Quebec will be well represented this year at BIO 2005, with a delegation representing 47 different Quebec companies and organizations, who will be participating in this major world-class biotechnology convention, taking place from June 19 to June 22, in Philadelphia, Pennsylvania.
According to a press release issued by the Quebec Premier's Office, Mr. Jean Charest will be participating in the official opening ceremony of the Convention on June 19, and in that of the Canadian pavilion the following day. The Quebec delegation is located in the latter. Meanwhile, the Minister of Economic Development, Innovation and Export Trade, Mr. Claude Bechard, will be taking advantage of his presence at BIO 2005 on June 21 to meet with the executive officers in the Quebec delegation.
"BIO 2005 constitutes an excellent opportunity for BIOQuebec to promote the expertise of our Quebec companies with numerous life science industry investors and partners", underlined the Executive Director of BIOQuebec, Mr. Perry Niro.
Nearly 18,000 visitors, from about sixty countries, as well as more than 1,000 exhibitors are expected in Philadelphia, an American city recognized for its thriving pharmaceutical industry. Last year, the Quebec delegation reaped more than $56 million in financing, research and distribution agreements during BIO 2004, held in San Francisco.
Led by BIOQuebec, in cooperation with Investissement Quebec, Montreal International, Canada Economic Development and the Ministry of the Economic Development, Innovation and Export Trade, the Quebec delegation to BIO 2005 will be made up of the following organizations and companies:
_________________________________________________________________________ Quebec Delegation _________________________________________________________________________ Aegera Therapeutics Genome Quebec Paladin Labs Gestion Univalor, Pole Quebec Limited Chaudiere- AEterna Zentaris Inc. Partnerships Appalaches AstraZeneca GlaxoSmithKline ProMetic BioSciences Biocean Novatech Inc. IBM Quintiles BioContact Quebec Investissement Quebec RBC Technology Ventures Bioniche Life Sciences Lapointe Rosenstein Sherbrooke Biomedical Park BIOQuebec Leger Robic Stikeman Elliot LLP BioSyntech Medicago Targanta Therapeutics Biotechnology MediCorp Technoparc Research Institute Saint-Laurent - NRC Canada's Research-Based Merck Frosst Canada The Biotech City Pharmaceutical Companies (Rx&D) Caprion Pharmaceuticals Milestone Pharmaceuticals Theratechnologies Chronogen Mistral Pharma Topigen Pharmaceuticals CNRC-Pari Montreal International Tranzyme Pharma Valeant Pharmaceuticals Desjardins Venture Capital Montreal InVivo International DNA Landmarks MSBi Capital Variation Biotechnologies Enobia Pharma Genizon BioSciences About BIOQuebec
BIOQuebec is an association grouping together nearly 250 innovative Quebec biotechnology and life science companies, whose mission is to support the growth and success of its members.BIOQUEBEC
CONTACT: Celine Vaillancourt, Director, Communications and Marketing,BIOQuebec, (514) 733-8411, poste 207, Cell.: (514) 264-9341, E-mail:email@example.com ; Source: Perry Niro, Executive Director,BIOQuebec, (514) 733-8411, poste 206, Cell.: (514) 265-8944, E-mail:firstname.lastname@example.org ; Website: www.bioquebec.com